Target intelligence / Profile preview

RNA, U7 small nuclear 25 pseudogene (RNU7-25P)

Target
RNU7-25P
Molecular classification
Other (Pseudogene), Small nuclear RNA pseudogene
01

Overview

RNA, U7 small nuclear 25 pseudogene (RNU7-25P) is a pseudogene of the U7 class of small nuclear RNAs, which are non-coding RNAs involved in the 3′ end processing of replication-dependent histone pre-mRNAs as part of the U7 small nuclear ribonucleoprotein complex[1][4][5]. RNU7-25P does not encode a functional product and is not known to have established biological roles, disease associations, or direct drug interactions. It is classified as a pseudogene—i.e., a defunct genetic element derived from duplication or mutation of functional U7 snRNA genes—and has no direct therapeutic, mechanistic, or biomarker relevance[1][5]. This distinguishes it from functional U7 small nuclear RNA genes, such as RNU7-1, which have roles in RNA processing and genetic disease, but RNU7-25P itself is not functional, not clinically relevant, and not a biomedical target. Key points: - RNU7-25P is a pseudogene, not a receptor, enzyme, transporter, or other "targetable" molecule. - It lacks known biological function or clinical significance. - Its name and abbreviation are standardized in public gene nomenclature databases, but the gene is non-functional[1][5][8]. - The target should be considered "incorrect" or "not applicable" in most biomedical or drug discovery contexts.

Other names
U7.25U7.25 RNAsmall nuclear U7.25 pseudogeneRNU7-25P

Beyond the preview

Go deeper on RNA, U7 small nuclear 25 pseudogene (RNU7-25P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U7 small nuclear 25 pseudogene (RNU7-25P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call